All
What Role May ctDNA Have in Melanoma Management?
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
An Expert Breaks Down Lymphedema Following Cancer Care
Dr. Sheri Yolanda Prentiss discusses the importance of seeking early intervention to detect lymphedema following cancer care.
Melanoma Taught Me Faith, Gratitude and That Nothing Is Permanent
I was diagnosed with stage 3 melanoma at 31, faced recurrence and now share my journey to raise awareness, stay hopeful and trust in God’s plan.
FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types
The FDA has approved Jobevne, a biosimilar to Avastin, for IV use in a number of cancer types.
Managing Cancer Demands With Flexibility and a Strategic Mindset
It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and patience.
FDA Grants Full Approval to Vitrakvi For NTRK-Positive Solid Tumors
Vitrakvi, first granted accelerated approval in 2018, has received full approval from the FDA.
Kaifan Zhao, AGACNP-BC, PMHNP-BC, Wins CURE’s 2025 Extraordinary Healer® Award
The 2025 Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology nursing professionals' dedication and impact.
First Patient Dosed in Trial of CT-95 in Mesothelin-Expressing Tumors
CT-95 is being developed for cancers including pancreatic, ovarian and mesothelioma and other solid tumors.
Early Detection and Screening is Key for Esophageal Cancer
Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.
Breaking Down Treatment Options for Patients With Head and Neck Cancer
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
Going Off Medication for Lymphoma: Could It Be True?
After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly taking me off of it.
PROSTOX May Predict Urinary Side Effects Post Prostate Cancer Radiation
A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.
Early Intervention and Screening Prevents Lymphedema After Cancer
Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.
FDA Grants Positive Review for AML Drug Trial, First Dosing in 2025
The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.
Cardiometabolic Considerations for Childhood Cancer Survivors Explained
The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood cancer.
Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.
FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer
The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.
Sometimes Cancer is a (Welcome) Distraction
In an upside-down, topsy-turvy world, cancer can be a distraction for us.
SLS009 May Improve Survival in R/R AML
SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.
A Patient Shares Insights on Kidney Cancer Awareness and Advocacy
Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and patient advocacy.
Bavencio Has Long-Term Benefit Regardless of Diabetes Status in Bladder Cancer
Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of patients’ diabetes status.
Raising Awareness for Kidney Cancer and the Challenges Patients Face
It is important to recognize Kidney Cancer Awareness Month as a time to get involved, as more than 600,000 people in the U.S. live with kidney cancer.
Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.
How ‘Man in the Mirror’ Reflects a Cancer Journey
I always wanted to make a difference, but I never expected my biggest impact to come through cancer.
BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.
How Biomarker Testing Can Shape a Breast Cancer Treatment Plan
Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.
Raising Awareness for Lymphedema Following a Cancer Diagnosis
Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following cancer treatment.
FDA Grants HLX22 Orphan Drug Designation for Gastric Cancer
FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.
Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Personalized Cancer Vaccine Generates Responses Across Cancer Types
PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer, as well as multiple myeloma.
